APA (7th ed.) Citation

P, M. R., J, M. G., O, E. F., A, H. G., & FJ, A. P. (2022). Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema. Cost effectiveness and resource allocation : C/E, 20(1), 61. https://doi.org/10.1186/s12962-022-00401-z

Chicago Style (17th ed.) Citation

P, Montes Rodríguez, Mateo Gabás J, Esteban Floría O, Honrubia Grijalbo A, and Ascaso Puyuelo FJ. "Cost-effectiveness of Dexamethasone Compared with Aflibercept in Naïve Diabetic Macular Edema." Cost Effectiveness and Resource Allocation : C/E 20, no. 1 (2022): 61. https://doi.org/10.1186/s12962-022-00401-z.

MLA (9th ed.) Citation

P, Montes Rodríguez, et al. "Cost-effectiveness of Dexamethasone Compared with Aflibercept in Naïve Diabetic Macular Edema." Cost Effectiveness and Resource Allocation : C/E, vol. 20, no. 1, 2022, p. 61, https://doi.org/10.1186/s12962-022-00401-z.